JAC Advance Access published online on June 24, 2008
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkn258
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial |
Randomized controlled trials in the Journal of Antimicrobial Chemotherapy
1 Department of Medicine E, Rabin Medical Center, Beilinson Campus, 49100 Petah-Tiqva, Israel 2 Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel Aviv, Israel 3 JAC Editorial Office, Griffin House, 53 Regent Place, Birmingham B1 3NJ, UK
* Corresponding author. Tel: +972-3937-6501; Fax: +972-3937-6512; E-mail: leibovic{at}post.tau.ac.il
Abstract
The Journal of Antimicrobial Chemotherapy welcomes submissions of well-reported randomized controlled trials (RCTs) with solid methodology based on the CONSORT statement (http://www.consort-statement.org). The Journal would be especially happy to publish RCTs in the area of antimicrobial chemotherapy if they address significant problems and look at measurable outcomes that matter to patients.
Key Words: evidence-based medicine , clinical outcomes